Echinococcosis: Epidemics and Economics by Torgerson, Paul R
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Echinococcosis: Epidemics and Economics
Torgerson, Paul R
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-137146
Accepted Version
Originally published at:
Torgerson, Paul R (2016). Echinococcosis: Epidemics and Economics. In: International Scientific-
Practical Conference ”Veterinary Medicine in the 21st Century - Problems, Methods and Solutions”,
Dedicated to the 100th Anniversary of the Birth of Professor Dr Nurgali Tassilovich Kadyrov, Astana,
Kazakhstan, 27 October 2016 - 28 October 2016, 8-12.
ECHINOCOCCOSIS: EPIDEMICS AND ECONOMICS
Torgerson, Paul., PhD, VetMB,  Professor
Section of Epidemiology
Vetsuisse Faculty, 
Zürich University, 
Switzerland
Introduction
Echinococcosis  is  amongst  the  world's  most  serious  parasitic  zoonoses.  Human  cystic
echinococcosis (CE) is caused by the larval stage of Echinococcus granulosus and results in a space
occupying lesion mainly in the liver or lungs and occasionally in other organs such as the central
nervous system [1]. It can cause serious human morbidity or even death if untreated. Dogs are the
normal definitive hosts and humans are infected by close contact with dogs or through contamination
of food or water with dog faeces containing eggs of  Echinococcus. Human alveolar echinococcosis
(AE)  is  caused  by  E.  multilocularis [1].  The  larval  stage  of  this  parasite  causes  a  serious  space
occupying lesion, initially in the liver but infiltrates and metastasises to other organs. It is usually fatal
if untreated [2]. AE can result from close contact with definitive hosts which include both foxes and
dogs or through contaminated food or water.
Epidemiology
CE has a global distribution. Hence it is found in most countries in the world [3]. The transmission
cycle is usually maintained through domestic farm animals, most commonly sheep but can include
cattle, goats, camels and others, and dogs. Dogs are infected through consumption of offal,  whilst
domestic animals are infected by grazing on contaminated pasture. The parasite is seen at the highest
prevalences where there is unregulated or poorly supervised slaughtering of domestic animals which
allows dogs  to  scavenge on offal  and hence  become infected  and further  transmit  the  parasite  to
humans.  The  highest  human  incidences  are  seen  in  western  China,  central  Asia,  eastern  Europe,
Mediterranean countries, parts of Sub-Saharan Africa and some Latin American countries. In recent
years in central Asia the incidence of CE has increased [4] and this may be the result of changes in
farming practices which included privatization and abandonment of many large meat processing units
that occurred following the dissolution of the Soviet Union. The increase in dog population is also a
significant contributing factor [5]. In Kazakhstan we have found high prevalences of CE in sheep
across southern districts of the country. These correspond to areas where the most human CE cases are
reported [6]. We have also found that farms dogs have the highest prevalence of infection of any dog
population, reaching 20% or more[7].
Increases in CE have been observed in eastern Europe for similar reasons [8,9]. Elsewhere the
disease is also strongly associated with poverty and unregulated home slaughtering of animals.
AE is entirely confined to the northern hemisphere and is found across northern Eurasia from
France in the west and Iran in the south to Siberia in the north and Japan in the east [10]. AE is also
found in Canada and northern parts of the USA. Across most of its range, the disease is sporadic and is
believed to be transmitted directly or indirectly from foxes to humans. In Europe we have been seeing
substantial increases in human AE across France, Switzerland, Austria, Germany, Poland and the Baltic
states  [11–15].  This  has  been  linked  to  dramatic  increases  in  fox  populations.  Foxes  have  also
colonized city environments which has increased the possibilities of transmission to humans. Further
east in central Asia there is also evidence of substantive increases in the numbers of human AE cases.
This is illustrated by the Kyrgyz Republic [16,17] where there are now reports in excess of 200 cases
per annum. The epidemiology of human CE in central Asia may be different, as there is evidence that
the parasite has colonized dogs and high prevalences of  E. multilocularis have been found in dog
populations  in  both  Kazakhstan  [18]  and  Kyrgyzstan  [19].  Dogs  have  much  closer  contact  with
humans and thus increase the likelihood of transmission. The colonization of dogs may be linked to the
increase in dog population and rural poverty. Feeding the dog is  not high priority so she will  go
hunting for small rodents and hence become infected. In the Kyrgyz republic in Naryn Oblast we have
found that hunting dogs and dogs allowed to roam have substantially higher prevalences than dogs that
are tied most of the time [19]. 
Further east in China there are huge numbers of cases of AE. China perhaps has over 90% of
all cases of human AE, with our estimates suggesting 16,000 or more cases per annum [10]. These
cases are largely confined to western China and the Tibetan plateau. In some communities prevalences
of 5% or more are found [20]. Often the communities with the highest prevalences are characterized
by extreme poverty and geographical isolation. There are often many stray dogs in these communities.
However, the local population does not have the resources to feed these dogs, whilst on the other hand
killing them is prohibited for religious reasons. Thus large populations of semi stray dogs will feed on
rodents and become infected. These dogs are allowed to freely wander in and out of the homes of the
local population, thus promoting transmission. Naturally the parasite transmits between rodents and
Tibetan foxes and these stray dogs have now created a domestic cycle which increases the risk to
humans. In addition degradation of the landscape, caused by overgrazing, has facilitated an increase in
population of susceptible rodent species which in turn has facilitated transmission of the parasite [21].
In the north the parasite is found throughout Russia and large numbers of case reports and case
series are in the literature from across Russia documenting hundred if not thousands of cases reported
since the middle of the last century (for examples see [22-24]). The epidemiology of transmission to
humans is less clear.
The parasite is now endemic in Hokkaido island in Japan, having been introduced with red
foxes in the early part of the last century. Approximately 10-20  human cases are reported annually
[25].
In  north  America,  the  only  substantial  numbers  of  human  cases  were  reported  from  St
Lawrence Island in Alaska [26] Elsewhere in north America, there has been widespread reports of
foxes  infected  with  E.  multilocularis,  but  human  cases  are  very  rare  [27].  This  might  change  as
recently European genotypes, possible imported with dogs into Canada have been recorded [28] . It is
hypothesized that European (or Asian) genotypes are much more likely to cause disease in humans
than the genotype predominantly found in north American foxes. 
Economics
Both forms of human echinococcosis are serious human diseases and expensive to treat. Surgical 
treatment of CE may cost US$1000 or more in a low income country, and several times that amount in 
a high income country [29]. With thousands of cases being treated annually in central Asia this results 
in a substantive economic burden. In addition, individuals may require prolonged nursing care whilst 
undergoing treatment resulting in substantial losses of income. Even where treatment is available, 
which, is often not the case in low income countries or remote areas, there is still a 2% case fatality 
rate during treatment. There is also evidence that even successfully treatment individuals are less able 
to work following recovery. 
Alveolar echinococcosis is much more difficult to treat. In Europe it may cost more than $100,000 
to treat an individual case of AE [2]. Following surgical resection of the lesion, patients then require a 
prolonged course of anthelmintic therapy for years or even life long to prevent recurrence. In severe 
cases liver transplantation may be the only option. In the absence of such aggressive treatment, the 
case fatality rate approaches 100%. 
CE also has substantive economics costs to livestock. These include the loss of edible offal, the 
decrease in productivity in terms of reduced meat, milk and wool production, [30-32] and decreased 
quality of meat[33] from infected animals. This is often overlooked but can be much higher than the 
direct costs to human health.
Control
CE can be successfully controlled or eliminated. This is achieved by regular treatment of dogs with
anthelmintics, control of slaughtered animals and education. Thus elimination of the disease was first
achieved in Iceland and later in New Zealand, Tasmania and Cyprus. These successful programmes
were on islands where reintroduction can be easily prevented.  Continental  systems are more of a
challenge.  However,  substantial  progress  has  been  made  in  some  Latin  American  countries  and
European countries. Recently there has also been the development of a vaccine  which can prevent
infection in sheep [34] and may prove a useful tool the control the disease. Despite the effort and
complexity required to successfully control and eliminate this parasite, it is highly cost effective and
should also be seen as an investment which will result in a positive return as well as a benefit to public
health.
Control of AE remains a challenge due to the parasite naturally occurring in wild life cycling
between foxes  and small  mammals.  Where  the  parasite  has  spilled  over  into  the  dog population,
regular treatment of dogs will ameliorate the risk to humans. Otherwise the mass treatment of foxes by
distributing  praziquantel  impregnated  baits  has  shown  success,  but  is  logistically  difficult  and
expensive.
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